Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

ormone della crescita

15 articoli — 1997-2025

RI Casi indimenticabili
Bassa statura: tutta colpa del papà

Tornese G.

2025/9 — pag. 598-600 — DOI

A child with slow growth and normal hormonal tests shows distinctive physical features. Clinical exome sequencing reveals a mutation in the IHH gene, inherited from the father, who had initially been overlooked. The child responds very well to growth...

RI Farmacoriflessioni
I LAGH (ormoni della crescita long-acting): cosa sono e a chi proporli?

Rodaro C, Tornese G.

2024/6 — pag. 371-375 — DOI

Children with growth hormone deficiency are currently treated with daily injections of recombinant growth hormone. The burden of 365 injections per year and cold chain storage causes a poor medication adherence. Long-acting growth hormones were devel...

RI Speciale
Endocrinologia e diabete

Chiarelli F, Faleschini E, Tornese G

2021/26 — pag. 4 — DOI

RI Aggiornamento
Decifrare la bassa statura nei bambini

Chiarelli F, Castorani V, Polidori N

2021/3 — pag. 159-166 — DOI

Short stature is the most common cause of referral to paediatricians. Only a minority of children with short stature have an underlying pathology. Although well-established diagnostic and management paradigms do exist, recent advances in molecular te...

RI Problemi speciali
Bassa statura da deficit di gene SHOX: vecchi e nuovi concetti

M.C. Pellegrin, S. Andrade, E. Faleschini, E. Barbi, C. Bizzarri, G. Tornese

2019/7 — pag. 438-444

At the moment alterations of SHOX gene, located in the pseudoautosomal region of sex chromosomes, are considered the most frequent genetic defects associated with short stature. Pathogenic mutations leading to SHOX deficiency involve not just exons...

RI Farmacoriflessioni
I farmaci biosimilari

A. Genazzani

2015/6 — pag. 386-388

The physico-chemical properties of biotechnological drugs are tightly linked to their manufacturing process. Yet, pharmaceutical companies that wish to make important manufacturing changes to their process may do so as long as they follow ICHQ5E gu...

RI Problemi speciali
Il deficit del gene SHOX come causa di bassa statura

L. Iughetti, S. Bernasconi, E. Caruso-Nicoletti, F. Chiarelli, A. Cicognani

2011/6 — pag. 367-373

SHOX gene (Short Stature Homeobox-containing gene) seems to play an important role in the growth process. Indeed, patients with mutations or deletions of this gene present with variable degrees of stature deficiency that in the most serious cases i...

RI Consensus
Linee guida sulla diagnosi e il trattamento del bambino con bassa statura idiopatica

F. Chiarelli, R. Salomone

2008/10 — pag. 626-633

ISS is defined auxologically by a height below -2 SDS without findings of disease after a complete evaluation by a pediatric endocrinologist (including bone age X-ray, thyroid function, karyotype for girls, and measurements of IGF-I and stimulated gr...

RI Consensus
Gestione della sindrome di Turner in età pediatricae durante la vita adulta

R. Salomone, F. Chiarelli

2008/3 — pag. 157-165

This consensus statement arose from an interdisciplinary meeting of geneticists, paediatricians, cardiologists, internists, behavioural health specialists, and gynaecologists involved in the care of and clinical research on patients with Turner Syn...

RI Linee guida
Accesso libero
Indicazioni all’uso dell’ormone della crescita

M. Pocecco

1998/8 — pag. 541

RI Novità
Accesso libero
Novità in Pediatria pratica 1996-1997

F. Panizon

1997/10 — pag. 649-674